Drawing for IMMUNESENSOR THERAPEUTICS

USPTO serial 88267270

IMMUNESENSOR THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 7012668Status 700Registered
Filing date
Status date
Registration date
Mar 28, 2023
Examiner
SINGLETON, RUDY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IMMUNESENSOR THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Kindel

Christopher M. Kindel PIRKEY BARBER PLLC1801 East 6th Street, Suite 300AUSTIN, TX 78702UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and biological preparations for use in the biological, biotechnological, medical, and pharmaceutical industries; Medicinal and biological preparations for research, laboratory, and medical laboratory use, namely, preparations used in the manufacture of pharmaceuticals for treating cancer and immunological diseasesACTIVENov 28, 2022
005Pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncologyACTIVEDec 7, 2022
042Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; Medical research; Research and development of pharmaceutical preparations for the treatment of cancer and immunological diseases; Providing medical and scientific research information in the fields of pharmaceuticals, biologicals, and clinical trialsACTIVEFeb 1, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 28, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 28, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 21, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 20, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 27, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 26, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 27, 2022IUAFUSE AMENDMENT FILED—
Dec 27, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 12, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 8, 2022EX4GSOU EXTENSION 4 GRANTED—
Jul 8, 2022EXT4SOU EXTENSION 4 FILED—
Jul 8, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 13, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 11, 2022EX3GSOU EXTENSION 3 GRANTED—
Jan 11, 2022EXT3SOU EXTENSION 3 FILED—
Jan 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 30, 2021EX2GSOU EXTENSION 2 GRANTED—
Jun 30, 2021EXT2SOU EXTENSION 2 FILED—
Jun 30, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2021EX1GSOU EXTENSION 1 GRANTED—
Jan 12, 2021EXT1SOU EXTENSION 1 FILED—
Jan 12, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 14, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 19, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 14, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 14, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 13, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 1, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 3, 2019ALIEASSIGNED TO LIE—
Sep 25, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 19, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 17, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 31, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2019DOCKASSIGNED TO EXAMINER—
Mar 21, 2019MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 22, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance